India: Intellectual Property

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

In 2024, roughly 26% of people came by a deep-fake scam online, with 9% falling victim to them. Furthermore, it is observed that "Face swaps" are among the most common deepfake categories, with a 704% increase from the first to the latter half of 2023.

In India's burgeoning fashion industry, piracy of designs is an evolving problem. Original designers have struggled to protect their work because of the rapid alterations in fashion...

Intellectual Property Rights (IPR) form the legal backbone for protecting creativity while ensuring that inventors, artists and writers retain control over their works which they have originally produced.

In recent years, global fashion houses have increasingly drawn inspiration from traditional Indian crafts and textiles.

In the rapidly evolving tech landscape, innovation and standardization are crucial for ensuring seamless interoperability between products and services.

The case of "Al-Hamd Tradenation vs Phonographic Performances Limited" centered on the issue of whether demanding exorbitant licensing fees constitutes a refusal under Section 31 of the Copyright Act, 1957, and whether such refusal would justify the grant of a compulsory license.

Biosimilar infringement disputes in India are still a comparatively new but growing field of pharmaceutical patent law. The Delhi High Court's Order dated 18 July 2025 in E.R. Squibb...

The Delhi High Court in a patent infringement suit between GSP Crop Sci. Pvt. Ltd. vs BR Agrotech Ltd [CS(COMM) 82/2023] involving insecticide Pyriproxyfen-Diafenthiuron agrochemical formulation of Patent (IN 394568).

Summary: India's new 2025 CRI Guidelines clarify patentability for computer-related inventions, which will impact applications in cutting edge areas, including AI, ML, and Blockchain technology.